Cyclerion Therapeutics Statistics

Total Valuation

CYCN has a market cap or net worth of $7.91 million. The enterprise value is $4.91 million.

Market Cap	7.91M
Enterprise Value	4.91M

Important Dates

The last earnings date was Tuesday, August 5, 2025, before market open.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	n/a

Share Statistics

CYCN has 3.20 million shares outstanding. The number of shares has increased by 8.63% in one year.

Current Share Class	3.20M
Shares Outstanding	3.20M
Shares Change (YoY)	+8.63%
Shares Change (QoQ)	+20.15%
Owned by Insiders (%)	22.97%
Owned by Institutions (%)	16.38%
Float	2.30M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.05
Forward PS	n/a
PB Ratio	0.89
P/TBV Ratio	0.92
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.26
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.03

Current Ratio	5.03
Quick Ratio	4.41
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -22.43% and return on invested capital (ROIC) is -27.05%.

Return on Equity (ROE)	-22.43%
Return on Assets (ROA)	-24.15%
Return on Invested Capital (ROIC)	-27.05%
Return on Capital Employed (ROCE)	-43.82%
Revenue Per Employee	$2.17M
Profits Per Employee	-$1.95M
Employee Count	1
Asset Turnover	0.22
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.67% in the last 52 weeks. The beta is 1.68, so CYCN's price volatility has been higher than the market average.

Beta (5Y)	1.68
52-Week Price Change	-17.67%
50-Day Moving Average	2.99
200-Day Moving Average	2.95
Relative Strength Index (RSI)	42.16
Average Volume (20 Days)	57,098

Short Selling Information

The latest short interest is 13,242, so 0.41% of the outstanding shares have been sold short.

Short Interest	13,242
Short Previous Month	17,184
Short % of Shares Out	0.41%
Short % of Float	0.58%
Short Ratio (days to cover)	0.23

Income Statement

In the last 12 months, CYCN had revenue of $2.17 million and -$1.95 million in losses. Loss per share was -$0.72.

Revenue	2.17M
Gross Profit	2.23M
Operating Income	-3.76M
Pretax Income	3.01M
Net Income	-1.95M
EBITDA	n/a
EBIT	-3.76M
Loss Per Share	-$0.72

Full Income Statement

Balance Sheet

The company has $3.01 million in cash and n/a in debt, giving a net cash position of $3.01 million or $0.94 per share.

Cash & Cash Equivalents	3.01M
Total Debt	n/a
Net Cash	3.01M
Net Cash Per Share	$0.94
Equity (Book Value)	8.57M
Book Value Per Share	2.79
Working Capital	3.22M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-2.83M
Capital Expenditures	n/a
Free Cash Flow	-2.83M
FCF Per Share	-$0.88

Full Cash Flow Statement

Margins

Gross margin is 102.62%, with operating and profit margins of -172.72% and -89.51%.

Gross Margin	102.62%
Operating Margin	-172.72%
Pretax Margin	-89.51%
Profit Margin	-89.51%
EBITDA Margin	n/a
EBIT Margin	-172.72%
FCF Margin	n/a

Dividends & Yields

CYCN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.63%
Shareholder Yield	-8.63%
Earnings Yield	-24.60%
FCF Yield	-35.73%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 16, 2023. It was a reverse split with a ratio of 1:20.

Last Split Date	May 16, 2023
Split Type	Reverse
Split Ratio	1:20

Scores

CYCN has an Altman Z-Score of -35.11 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-35.11
Piotroski F-Score	1